Description
EMRAPOL E-974P, also known as ACRYPOL 974P, is a high molecular weight, cross-linked, water-soluble polymer of acrylic acid. It’s a synthetic ingredient primarily used in the pharmaceutical and cosmetic industries as a thickening, emulsifying, and stabilizing agent. Specifically, it’s employed in oral care products, topical formulations, and sustained-release tablets.
Here’s a more detailed breakdown:
Key Properties and Uses:
Thickening Agent:
EMRAPOL E-974P effectively increases the viscosity of formulations, allowing for the creation of gels, creams, and other products with desired textures.
Emulsifying Agent:
It helps to stabilize emulsions, preventing the separation of oil and water phases in formulations.
Stabilizing Agent:
It contributes to the overall stability of formulations, ensuring that they maintain their desired properties over time.
Oral Care:
It is used in oral liquids, bioadhesive formulations, and extended-release tablets.
Topical Applications:
It can be found in skin creams, lotions, and other topical products.
Sustained Release:
Its cross-linked structure allows for the development of formulations with controlled drug release, especially in tablet applications.
USP/NF Grade:
EMRAPOL E-974P typically meets the standards of the United States Pharmacopeia (USP) and National Formulary (NF), indicating its suitability for pharmaceutical use.
Specific Applications:
Toothpaste: It is used to thicken and stabilize toothpaste formulations.
Oral Liquids: It can be used to create stable suspensions and emulsions for oral administration.
Sustained-Release Tablets: It plays a role in controlling the release of active ingredients in extended-release tablet formulations.
Skin Creams and Lotions: It provides the desired viscosity and stability to these products.
Eye Drops: It can be found in some formulations for dry eye treatment.
Ophthalmic Gels: It is used in gels for ophthalmic applications.
Taste Masking: It can be used to improve the taste of certain medications.
Reviews
There are no reviews yet.